918博天堂(中国)

Product logins

Find logins to all Clarivate products below.


Disease Landscape and Forecast

Maximize the value of your assets with in-depth indication-specific market intelligence

Optimize your disease strategy with market landscape data and analysis

Uncover high-potential markets and position your product for success with disease landscape insights

Play video

Assess and prioritize opportunities

Appraise market potential for your assets – and those of your competitors – and optimize your strategy with indication-specific market intelligence combined with world-class epidemiology.

Identify unmet needs

Evaluate areas of unmet need and direct your clinical development strategy to the areas with the greatest opportunity.

Fuel successful market access

Enhance your market access strategy with brand-level insight regarding the impact of payer policy on physician prescribing behavior.

Quickly understand the disease market landscape

Extensive therapy area coverage

Access detailed market outlook for 85+ indications, including rare and niche, plus executive insights for an additional 45+ diseases.

Broad and deep insights

Comprehensive syndicated insights featuring market dynamics, constraints, drivers, and unmet needs coupled with 10-year sales forecasts.

Unparalleled domain expertise

Our industry and disease specialists - including analysts, therapy area experts, epidemiologists, data scientists, physicians and pharmacists - have intricate knowledge of therapy areas and markets globally.

Comprehensive market intelligence to optimize your disease strategy

Forecast with confidence

Using a bottom-up forecasting methodology based on top-line epidemiology data, our 10-year, annualized market forecasts feature drug-level sales and patient shares of key therapies segmented by brands/generics.

Dive deeper into disease management insights

Featuring primary market research and RWD – including patient-level claims data – our in-depth insights into critical areas of treatment analysis, unmet need, and access & reimbursement span 130+ diseases and topics.

Optimize your strategy in China

Geographically diverse insights to help your business succeed in this lucrative market, featuring world-class epidemiology, insight into the complex access and reimbursement environment, current treatment paradigms data, and 10-year, annualized, drug-level forecasts.

Access Our Disease Market Landscape & Forecasting Analytics

Develop your long-term disease strategy with confidence

85+
detailed market outlook for 85+ indications
10yr
annualized, bottom-up 10-year forecasts for the G7 markets
100+
expert analyst team, including therapy area experts and epidemiologists

Get the full story of a disease​

Biosimilars

Size opportunities and threats in this lucrative market

Epidemiology Intelligence

Size your market accurately with comprehensive epidemiology data

Cortellis Competitive Intelligence

Make critical portfolio decisions backed by comprehensive pipeline and pharma competitive intelligence